Inventor
HAY DUNCAN ALEXANDER
GB10 patents
⚠️ This page may combine multiple inventors who share the name “HAY DUNCAN ALEXANDER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ENTERPRISE THERAPEUTICS LTD
6 patentsUS12037336B2Jul 16, 2024
Compounds with activity as inhibitors of the epithelial sodium channel (ENaC)
ENTERPRISE THERAPEUTICS LTD3 citations71
US12371436B2Jul 29, 2025
Substituted benzodiazoliums as ENaC inhibitors
ENTERPRISE THERAPEUTICS LTD0 citations58
US11739094B2Aug 29, 2023
Substituted benzodiazoliums as ENaC inhibitors
ENTERPRISE THERAPEUTICS LTD0 citations58
US10941149B2Mar 9, 2021
Substituted benzodiazoliums as ENaC inhibitors
ENTERPRISE THERAPEUTICS LTD0 citations58
US11370778B2Jun 28, 2022
Bis(pentahydroxyhexyl)amino substituted 2-{[(3-amino-pyrazin-2-yl)formamido]methyl}-1H-1,3-benzodiazol-3-ium derivatives as ENaC inhibitors for treating respiratory diseases
ENTERPRISE THERAPEUTICS LTD0 citations48
US10759785B2Sep 1, 2020
Compounds
ENTERPRISE THERAPEUTICS LTD0 citations37
TMEM16A LTD
4 patentsUS11364246B2Jun 21, 2022
Compounds
TMEM16A LTD2 citations62
US12377105B2Aug 5, 2025
Compounds
TMEM16A LTD0 citations52
US12552770B2Feb 17, 2026
Compounds for treating respiratory disease
TMEM16A LTD0 citations47
US12415793B2Sep 16, 2025
Modulators of TMEM16A for treating respiratory disease
TMEM16A LTD0 citations47